BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
+42.04%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.01B
AUM Growth
+$128M
Cap. Flow
-$242M
Cap. Flow %
-12.04%
Top 10 Hldgs %
57.08%
Holding
77
New
4
Increased
7
Reduced
4
Closed
25

Top Buys

1
ARGX icon
argenx
ARGX
$28.5M
2
ARVN icon
Arvinas
ARVN
$25.1M
3
GPCR icon
Structure Therapeutics
GPCR
$16.3M
4
TNGX icon
Tango Therapeutics
TNGX
$10.6M
5
IMVT icon
Immunovant
IMVT
$10.5M

Top Sells

1
AMLX icon
Amylyx Pharmaceuticals
AMLX
$38.2M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$36.5M
3
VTYX icon
Ventyx Biosciences
VTYX
$29.5M
4
FOLD icon
Amicus Therapeutics
FOLD
$28.3M
5
EXEL icon
Exelixis
EXEL
$25.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KALV icon
26
KalVista Pharmaceuticals
KALV
$796M
$20.2M 1.01%
1,650,000
– –
RLAY icon
27
Relay Therapeutics
RLAY
$710M
$20M 1%
1,819,132
– –
ITOS
28
DELISTED
iTeos Therapeutics
ITOS
$19.8M 0.98%
1,804,058
– –
DAWN icon
29
Day One Biopharmaceuticals
DAWN
$773M
$17.4M 0.87%
1,189,943
– –
GPCR icon
30
Structure Therapeutics
GPCR
$1.27B
$16.3M 0.81%
+400,000
New +$16.3M
ORIC icon
31
Oric Pharmaceuticals
ORIC
$1.06B
$15.9M 0.79%
1,732,571
– –
IOVA icon
32
Iovance Biotherapeutics
IOVA
$901M
$11.4M 0.57%
1,400,000
-2,305,133
-62% -$18.7M
PRLD icon
33
Prelude Therapeutics
PRLD
$69.6M
$11M 0.55%
2,568,287
+73,269
+3% +$313K
RNA icon
34
Avidity Biosciences
RNA
$6.48B
$10.1M 0.51%
1,121,327
– –
NKTX icon
35
Nkarta
NKTX
$161M
$9.5M 0.47%
+1,440,000
New +$9.5M
ELVN icon
36
Enliven Therapeutics
ELVN
$1.19B
$8.94M 0.45%
646,058
– –
THRD
37
DELISTED
Third Harmonic Bio
THRD
$8.23M 0.41%
750,000
+229,583
+44% +$2.52M
ZNTL icon
38
Zentalis Pharmaceuticals
ZNTL
$126M
$6.82M 0.34%
450,000
– –
GERN icon
39
Geron
GERN
$893M
$6.33M 0.32%
3,000,000
– –
SYRE icon
40
Spyre Therapeutics
SYRE
$1.03B
$5.38M 0.27%
+250,000
New +$5.38M
OBIO icon
41
Orchestra BioMed
OBIO
$148M
$2.17M 0.11%
238,193
– –
FATE icon
42
Fate Therapeutics
FATE
$116M
$1.87M 0.09%
500,000
– –
KOD icon
43
Kodiak Sciences
KOD
$556M
$1.82M 0.09%
600,000
– –
BCAB icon
44
BioAtla
BCAB
$31.5M
$1.69M 0.08%
686,347
– –
BDTX icon
45
Black Diamond Therapeutics
BDTX
$167M
$1.42M 0.07%
506,000
– –
RAIN
46
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$1.38M 0.07%
1,152,212
– –
MIST icon
47
Milestone Pharmaceuticals
MIST
$153M
$516K 0.03%
309,007
– –
DBVT
48
DBV Technologies
DBVT
$245M
$476K 0.02%
50,000
-48,510
-49% -$462K
TARA icon
49
Protara Therapeutics
TARA
$122M
$392K 0.02%
209,227
– –
BCEL
50
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$291K 0.01%
2,202,333
– –
1
2
3 4